Population Genomics and its Impact on the Community

Population Genomics and its Impact on the Community
Preventative Genetics Screening: Learnings from the Healthy Nevada Project

Tuesday, October 8, 2019
1 - 2 p.m. Eastern; noon - 1 p.m. Central; 10 - 11 a.m. Pacific
 

Large-scale preventative genetic screening has the potential to identify millions of individuals who are at a higher risk of developing genetic conditions. The Healthy Nevada Project was established by Renown Institute for Health Innovation (IHI) and Helix, a population genomics company, with the goal of sequencing and screening 250,000 Nevadans for three highly actionable genetic conditions.

Population-level genetic screening for these conditions has the potential to identify many of these individuals before the disease has manifested, allowing for early medical intervention that can improve patient outcomes and lower health care costs. Screening can also be a valuable engagement tool for health systems looking to broaden their reach within the communities they serve by attracting new patients and increasing engagement with existing patients. In this webinar, leaders from Renown Health and Helix discuss how the Healthy Nevada Project came to be and its impact on patients thus far.

Attendees Will Learn:

● The solutions necessary to overcome challenges in implementing large-scale preventative genetic screening.
● The potential impact that a large-scale preventative genetic screening project can have on a health system and the community it serves.
● The value in strategic partnerships, such as the collaboration between Renown IHI and Helix.
 

Speakers:

Anthony Slonim, MD, DrPH, FACHE
President and Chief Executive Officer
Renown Health
Reno, Nev.
 

James Lu, M.D. Ph.D.
Co-founder & Senior Vice President of Applied Genomics
Helix
San Francisco, Calif.